Delirium accompanied by fever could be an early symptom of COVID-19

NewsGuard 100/100 Score

Delirium accompanied by fever could be an early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya (UOC) .

The study is published in the open access Journal of Clinical Immunology and Immunotherapy, which highlights the fact that, together with the loss of the senses of taste and smell and headaches that occur in the days prior to the manifestation of coughing and breathing difficulties, some patients also develop delirium.

As such, the manifestation of this state of confusion, when accompanied by high fever, should be considered an early marker of the disease, particularly in the case of elderly patients.

"Delirium is a state of confusion in which the person feels out of touch with reality, as if they are dreaming," explained UOC researcher Javier Correa, who carried out this study at the University of Bordeaux (France).

He added that "we need to be on the alert, particularly in an epidemiological situation like this, because an individual presenting certain signs of confusion may be an indication of infection".

Correa, together with UOC Cognitive Neuro Lab researcher Diego Redolar Ripoll, has reviewed the body of scientific work published on the effects of COVID-19 in relation to the central nervous system, i.e. the brain.

The review found that, although to date much of the coronavirus research conducted since the first cases of pneumonia were reported in China (on 31 December 2019) have focused on the damage it causes to the lungs and other organs, such as the kidneys and heart, there are growing indications that the coronavirus also affects the central nervous system and produces neurocognitive alterations, such as headaches and delirium, as well as psychotic episodes.

The main hypotheses which explain how the coronavirus SARS-CoV-2 affects the brain point to three possible causes:hypoxia or neuronal oxygen deficiency,inflammation of brain tissue due to cytokine storm and the fact that the virus has the ability to cross the blood-brain barrier to directly invade the brain."

Javier Correa, Researcher, Open University of Catalonia

He stressed that any one of these three factors has the potential to result in delirium and explained that evidence of hypoxia-related brain damage has been observed in autopsies carried out on patients who have died from the infection and that it has been possible to isolate the virus from the cerebral tissue.

According to the researchers, delirium, cognitive deficits and behavioral anomalies are most likely to be the result of systemic inflammation of the organ and a state of hypoxia, which also causes the neuronal tissue to become inflamed and cause damage in areas such as the hippocampus, which are associated with the cognitive dysfunctions and behavioral alterations presented by patients suffering delirium.

Source:
Journal reference:

Vázquez, J.C & Redolar-Ripoll, D (2020) Delirium in Severe Acute Respiratory SyndromeCoronavirus-2 Infection: A Point of View. Journal of Clinical Immunology and Immunotherapy. doi.org/10.24966/CIIT-8844/1000039.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The association between handgrip strength and functional outcomes in long COVID-19